MS4A1

Green MS4A1 in COVID-19 research

Level 2: Viral research
Version 1.142

Sources

• Expert Review Green
• IUIS Classification February 2018
• IUIS Classification December 2019
• GRID V2.0
• Victorian Clinical Genetics Services
• ESID Registry 20171117
• IUIS Classification December 2019
• IUIS Classification February 2018
• Victorian Clinical Genetics Services
• ESID Registry 20171117
• GRID V2.0

Phenotypes

• Recurrent infections
• Common variable immunodeficiency disorders (CVID)
• Predominantly Antibody Deficiencies
• Immunodeficiency, common variable, 5 613495

Red MS4A1 in Primary immunodeficiency or monogenic inflammatory bowel disease

Version 5.1
Latest signed off version: v5.0 (1 May 2024)

Sources

• IUIS Classification December 2019
• Expert Review Red
• IUIS Classification February 2018
• Victorian Clinical Genetics Services
• ESID Registry 20171117
• GRID V2.0

Phenotypes

• Common variable immunodeficiency disorders (CVID)
• Recurrent infections
• Immunodeficiency, common variable, 5 613495
• Predominantly Antibody Deficiencies

Green MS4A1 in Severe Paediatric Disorders

Version 1.184

Sources

• Next Generation Children Project
• Expert Review Green
• Expert list

Phenotypes

• Immunodeficiency, common variable, 5, 613495